Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Aust N Z J Med ; 29(2): 214-9, 1999 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10342020

RESUMO

BACKGROUND: To examine prognostic factors, treatment outcomes and design future studies for Osteolymphoma (OL)--also known as primary bone lymphoma. METHODS: Between 1979 and 1993, 70 patients with OL were treated in nine Australian centres. The effect of patient-, tumour-, and treatment-related factors on local control, distant disease-free survival and overall survival were assessed by multivariate analysis. RESULTS: Most patients (94%) received radiotherapy (RT) (median dose 40 Gy) and 56% received chemotherapy. Multifocal disease was present in 20% of patients. The five year rates of overall survival and local control were 59% and 82%. Although there was a trend towards better results with the addition of chemotherapy, on multivariate analysis, there were no factors identified which appeared to impact upon overall and disease-free survival. Among the distant recurrences, there was a high proportion in bone (33%). Six patients suffered pathological fractures after treatment. CONCLUSION: High rates of local control were achieved by RT, but the overall survival remains relatively poor, worse than nodal lymphoma. The natural history of the disease suggests that OL may be a distinct entity, different to nodal lymphomas, so the results of clinical trials in nodal lymphoma may not be relevant to OL. Prospective studies could define the outcome of combined modality therapy and set a benchmark for testing further proposals, as well as improving our knowledge of the clinical features of OL.


Assuntos
Neoplasias Ósseas , Linfoma não Hodgkin , Adulto , Idoso , Idoso de 80 Anos ou mais , Antineoplásicos/uso terapêutico , Neoplasias Ósseas/tratamento farmacológico , Neoplasias Ósseas/mortalidade , Neoplasias Ósseas/radioterapia , Intervalo Livre de Doença , Feminino , Seguimentos , Humanos , Linfoma não Hodgkin/tratamento farmacológico , Linfoma não Hodgkin/mortalidade , Linfoma não Hodgkin/radioterapia , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Prognóstico , Taxa de Sobrevida , Resultado do Tratamento
2.
Nurs Times ; 90(29): 37-9, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-8058493

RESUMO

This paper provides a sensitive account of the nursing and social care given to a man dying of motor neurone disease. The emphasis of this care study is on the importance of the involvement of the patient and his wife in the discussions about his care and the value of ensuring that the couple retained a measure of control up to the death of the husband.


Assuntos
Cuidados Paliativos na Terminalidade da Vida , Doença dos Neurônios Motores/diagnóstico , Doença dos Neurônios Motores/enfermagem , Esclerose Lateral Amiotrófica/diagnóstico , Diagnóstico Diferencial , Humanos , Masculino , Pessoa de Meia-Idade
4.
Artigo em Inglês | MEDLINE | ID: mdl-3489690

RESUMO

The proliferation of human blood lymphocytes from ageing donors, responding to concanavalin A, showed greater sensitivity to inhibition by X-rays than similar cells from younger donors. This increased sensitivity was associated with deficiency in repair of X-ray-induced damage to nuclear material, as measured by density in sucrose gradients, and with increased incidence of chromosomal damage following exposure of freshly isolated lymphocytes. There was also an increased frequency of spontaneous chromosomal aberrations in ageing subjects whose lymphocytes were deficient in repair of DNA damage.


Assuntos
Envelhecimento/sangue , Linfócitos/efeitos da radiação , Idoso , Idoso de 80 Anos ou mais , Envelhecimento/genética , Envelhecimento/imunologia , Aberrações Cromossômicas , Reparo do DNA , Feminino , Humanos , Ativação Linfocitária/efeitos da radiação , Linfócitos/imunologia , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...